spacer
home > white papers > Case Study: Emerade® Auto-Injector - SHL Group
WHITE PAPERS
logo_SHL_Groupl.jpg

SHL Group

phone +886 3 217 0303
email info@shl-group.com
web http://www.shl-group.com/
email No.136 Kuo Sheng 2nd Street, Taoyuan, Taiwan 330

Case Study: Emerade® Auto-Injector


spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Countdown to the UK’s leading production line event begins

The manufacturing sector has just achieved its longest period of expansion since 1968, boosted by global economic growth and the weakened pound, while early signs reveal that Britain’s manufacturers are on track to outpace the rest of the economy – setting the year on a strong path for growth.
More info >>


White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>


Industry Events

Clinical Trial Supply Nordics 2018

19-20 June 2018, Copenhagen, Denmark

Building on last year’s success, our CTS team have conducted extensive research to ensure the 2018 event programme covers all the essentials in clinical supply. In the current climate, every pharma and biotech company are trying to reduce unwanted costs, and enhance operational efficiency. To avoid costly setbacks, an innovative and effective strategy needs to be implemented!
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement